scholarly journals Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.

Circulation ◽  
1994 ◽  
Vol 90 (4) ◽  
pp. 2032-2040 ◽  
Author(s):  
J Wang ◽  
J Feng ◽  
S Nattel
Keyword(s):  
Atrial Fibrillation ◽  
Antiarrhythmic Drug ◽  
Drug Action ◽  
Class Iii ◽  
Class Iii Antiarrhythmic Drug ◽  
Antiarrhythmic Drug Action

Effects of a New Class III Antiarrhythmic Drug Nibentan in a Canine Model of Vagally Mediated Atrial Fibrillation

2000 ◽  
Vol 36 (1) ◽  
pp. 77-89 ◽  
Author(s):  
Vadim V. Fedorov ◽  
Oleg F. Sharifov ◽  
Galina G. Beloshapko ◽  
Anna V. Yushmanova ◽  
Leonid V. Rosenshtraukh
Keyword(s):  
Atrial Fibrillation ◽  
Antiarrhythmic Drug ◽  
Canine Model ◽  
Class Iii ◽  
New Class ◽  
Class Iii Antiarrhythmic Drug

Bepridil Prevents Paroxysmal Atrial Fibrillation by a Class III Antiarrhythmic Drug Effect

2003 ◽  
Vol 26 (1p2) ◽  
pp. 314-317 ◽  
Author(s):  
TORU YOSHIDA ◽  
SHINICHI NIWANO ◽  
KIMIATSU INUO ◽  
JUNKO SAITO ◽  
JISHO KOJIMA ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Antiarrhythmic Drug ◽  
Paroxysmal Atrial Fibrillation ◽  
Drug Effect ◽  
Class Iii ◽  
Class Iii Antiarrhythmic Drug

scholarly journals Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.

Circulation ◽  
1993 ◽  
Vol 88 (3) ◽  
pp. 1030-1044 ◽  
Author(s):  
J Wang ◽  
G W Bourne ◽  
Z Wang ◽  
C Villemaire ◽  
M Talajic ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Antiarrhythmic Drug ◽  
Drug Action ◽  
Antiarrhythmic Drug Action
Sign in / Sign up

Export Citation Format

Share Document